HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma.

Abstract
Thin melanomas are tumors less than 1 mm thick according to Breslow classification. Their prognosis is in most cases excellent. However, a small subset of these tumors relapses. These clinical findings emphasize the need of novel prognostic biomarkers to identify this subset of tumors. Characterization of tumor immune microenvironment (TIME) is currently investigated as a prognostic and predictive biomarker for cancer immunotherapy in several solid tumors including melanoma. Here, taking into account the limited availability of tumor tissues, by characterizing some of the characteristics of TIME such as number of infiltrating lymphocytes, HLA class I antigen and PD-L1 expression, we show that number of infiltrating CD8+ and FOXP3+ T cells as well as CD8+/FOXP3+ T cell ratio can represent a useful prognostic biomarker in thin melanoma. Although further investigations in a larger patient cohort are needed, these findings have potential clinical significance since they can be used to define subgroups of thin melanoma patients who have a worse prognosis and might need different treatment modalities.
AuthorsFrancesco Sabbatino, Giosuè Scognamiglio, Luigi Liguori, Antonio Marra, Anna Maria Anniciello, Giovanna Polcaro, Jessica Dal Col, Alessandro Caputo, Anna Lucia Peluso, Gerardo Botti, Pio Zeppa, Soldano Ferrone, Stefano Pepe
JournalFrontiers in immunology (Front Immunol) Vol. 11 Pg. 561390 ( 2020) ISSN: 1664-3224 [Electronic] Switzerland
PMID33117345 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Sabbatino, Scognamiglio, Liguori, Marra, Anniciello, Polcaro, Dal Col, Caputo, Peluso, Botti, Zeppa, Ferrone and Pepe.
Chemical References
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • CD274 protein, human
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Histocompatibility Antigens Class I
Topics
  • Adult
  • Aged
  • B7-H1 Antigen (metabolism)
  • Biomarkers, Tumor (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Forkhead Transcription Factors (metabolism)
  • Histocompatibility Antigens Class I (immunology)
  • Humans
  • Kaplan-Meier Estimate
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Male
  • Melanoma (immunology, pathology)
  • Middle Aged
  • Prognosis
  • Skin Neoplasms (immunology, pathology)
  • T-Lymphocytes, Regulatory (immunology)
  • Tumor Microenvironment (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: